Claus I, Hoffmeister M, Strathmeyer S, et al. Metabolomics for Distinguishing Cardiovascular Risk in Rheumatoid Arthritis Across Different Disease-Modifying Antirheumatic Drug Therapies. J Clin Med Res. 2025;17(2):89-96. doi:10.14740/jocmr6145